Medicine News and Research

RSS

Children's of Alabama extends its commitment to Allscripts Sunrise EHR solutions

Allscripts has announced that Birmingham-based Children's of Alabama has extended its commitment to Allscripts Sunrise™ electronic health record (EHR) through 2023 and will leverage a suite of Allscripts open platform solutions to support its efforts to meet regulatory requirements, manage population health and improve patient outcomes.

30 Jun 2014

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

Merck, known as MSD outside the United States and Canada, today announced results from a global, investigational Phase 3 study to evaluate the safety and efficacy of EMEND (aprepitant) in the prevention of chemotherapy-induced nausea and vomiting (CINV) in pediatric cancer patients, aged 6 months to 17 years.

30 Jun 2014

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

The omega-3 polyunsaturated fatty acids (PUFAs) found in seafood and marine oils called EPA and DHA may offer a simple, affordable way to reduce the effects of traumatic brain and spinal cord injuries by decreasing inflammation and nerve cell damage.

30 Jun 2014

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

30 Jun 2014

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)

30 Jun 2014

Complete analysis of regenerative medicine market

According to a new market research report by Allied Market Research titled, "GlobalRegenerative MedicineMarket (Technology, Applications, Geography) - Industry Analysis, Trends, Opportunities and Forecast, 2013-2020", the global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020).

30 Jun 2014

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.

30 Jun 2014

Bacteria can survive under antibiotic exposure by developing a biological timer

Hebrew University of Jerusalem researchers showed that when exposed to repeated cycles of antibiotics, bacteria evolved a new adaptation by remaining dormant for the treatment period. The results show for the first time that bacteria can develop a biological timer to survive under antibiotic exposure.

30 Jun 2014

Victory Healthcare continues its commitment to honor America's wounded warriors

Victory Healthcare continues its corporate-wide commitment to honor America's wounded warriors and the sacrifice they and their families made for our freedom by implementing employee philosophies and practices.

30 Jun 2014

Video interview highlights latest research developments in women’s reproductive health using Chromatrap solid state ChIP assay

An informative video interview with Professor Steve Conlan of the College of Medicine at Swansea University (UK) highlights the latest research developments in women’s reproductive health using unique molecular biology tools.

From Chromatrap® - Porvair Sciences Ltd 30 Jun 2014

Novel method triples length of time organs can be preserved for transplantation

A system developed by investigators at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine allowed successful transplantation of rat livers after preservation for as long as four days, more than tripling the length of time organs currently can be preserved.

30 Jun 2014

New less expensive method to enrich stable isotopes

Researchers at The University of Texas at Austin have devised a new method for enriching a group of the world's most expensive chemical commodities, stable isotopes, which are vital to medical imaging and nuclear power, as reported this week in the journal Nature Physics. For many isotopes, the new method is cheaper than existing methods. For others, it is more environmentally friendly.

30 Jun 2014

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today detailed findings from its global Phase III RECOURSE trial of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug.

28 Jun 2014

Viewpoints: Abortion rights buffer; coming 'freakout' on health law; repercussions of malaria prevention

A Unanimous Supreme Court: Abortion Rights Lose A Buffer Yet on Thursday the Supreme Court, in McCullen v. Coakley, struck down that law for violating the First Amendment.

28 Jun 2014

American Academy of Ophthalmology does not recommend marijuana for glaucoma treatment

The American Academy of Ophthalmology – the world's largest association of eye physicians and surgeons – is reminding the public that it does not recommend marijuana or other cannabis products for the treatment of glaucoma.

28 Jun 2014

Karolinska Institute Professor calls for innovative solutions for global healthcare

Einstein once observed that "it is harder to crack prejudice than an atom". If he was right, then Hans Rosling is faced with a labour of Hercules.

28 Jun 2014

Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern.

28 Jun 2014

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

University of Iowa researchers have discovered a new form of neurotransmission that influences the long-lasting memory created by addictive drugs, like cocaine and opioids, and the subsequent craving for these drugs of abuse. Loss of this type of neurotransmission creates changes in brains cells that resemble the changes caused by drug addiction.

28 Jun 2014

Members of JUGGLE network collaborate to improve project coordination

The field of life sciences is at the crossroads of biology and medicine and is a key component of the research portfolio of Johannes Gutenberg University Mainz (JGU).

28 Jun 2014

Study calls for more proactive approach towards complete dyslipidemia diagnosis in clinical practice

Clinical inertia does not allow healthcare professionals to diagnose cholesterol problems in the 65.3% of cases. The results warn of the need to adopt a more proactive attitude towards a complete dyslipidemia diagnosis in routine clinical practice, especially if it is taken into account that it is an illness related to an increase of cardiovascular risk.

28 Jun 2014

Medicine News and Research

Children's of Alabama extends its commitment to Allscripts Sunrise EHR solutions

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Complete analysis of regenerative medicine market

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

Bacteria can survive under antibiotic exposure by developing a biological timer

Victory Healthcare continues its commitment to honor America's wounded warriors

Video interview highlights latest research developments in women’s reproductive health using Chromatrap solid state ChIP assay

Novel method triples length of time organs can be preserved for transplantation

New less expensive method to enrich stable isotopes

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Viewpoints: Abortion rights buffer; coming 'freakout' on health law; repercussions of malaria prevention

American Academy of Ophthalmology does not recommend marijuana for glaucoma treatment

Karolinska Institute Professor calls for innovative solutions for global healthcare

Psychostimulant increases risk of cardiovascular events in children with ADHD

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

Members of JUGGLE network collaborate to improve project coordination

Study calls for more proactive approach towards complete dyslipidemia diagnosis in clinical practice

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News